Title:
|
Science and Policy of Low Dose Risk : The Case for Bisphenol-A Human Endocrine Modulation
|
This thesis examines the origins of estrogen related HEM as a science-policy concept
that emerged during a period of socio-political ambiguity in the 199Os. The thesis tracks
a complex pattern of reciprocal influence between science and policy (mainly European)
in the regulation of synthetic chemicals, low dose exposure, and HEM - with reference to
BPA. Specifically, the thesis demonstrates that precautionary appraisal procedures
changed the involvement and weighting of basic science in decision-making processes.
From this position it suggests that the precautionary principle (PP) made regulatory
knowledge processes for chemicals more reflexive to experimental hypotheses relating
human health to environmental estrogens.
It is argued that by harnessing basic science in this way to address user-oriented issues,
the PP evolved a highly reflexive science-policy model with analytic and deliberative
procedures to drive, produce, distribute and evaluate scientific knowledge. However, the
dynamics provoked by these procedures (arOlmd EM theory) caused the system to
oscillate between different states of nomological possibility and epistemic risk which,
for chemicals like BPA, broke down to perpetuate an indefinite cycle of research. It
appears that this cycle becomes harder to break when technical and social uncertainties
act together to motivate further research so that the system becomes almost selfregulating,
building a 'body of knowledge' around a perceived problem (male
reproductive disorders).
In conclusion the thesis argues that the societal response to chemical concerns stimulated
a different form of scientific and social scrutiny, reflexive to the motivations and
perspectives of precautionary policy, scientific conjecture, and public perception. This
changed the nature of technical evidence counting as policy relevant knowledge, which
has made it difficult to bring closure to the hazard assessments associated with BP A, and
indicates the potential for future difficulties in regulatory science.
|